abstract |
The present invention relates to 6-(2-furyl)-3-methyl-4-oxo-1,5,6,7-tetrahydroindole-2- carboxylate derivatives, to a process for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders including cancer, preferably multidrug resistant cancer. |